Wednesday, October 14, 2015

GUJARAT THEMIS BIOSYN LTD (506879) :- HIDDEN GEM

Dear readers,




   Today we are looking to  another pharma stock after success  of  'sunil healthcare" ,




   

         "GUJARAT THEMIS BIOSYN LTD"

                                                         Gujarat Themis Biosyn Limited

India’s first company to start commercial production of Anti-tuberculosis drug Rifampicin

    

    Incorporated in 1981 as a joint sector company with GIIC Ltd. and Chemosyn (P) Ltd. Commenced production in August, 1985 by producing Erythromycin and Erythromycin salts and formulations. The Company was taken over during June 1991 by Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug Companies – Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd.. The Company entered into Technical & Financial collaboration with Yuhan Corporation, South Korea. With Yuhan’s know-how, GTBL became India’s first Company to start commercial production of Anti-tuberculosis drug Rifampicin.


                Group Companies


                   PRODUCTS


1. Rifamycin-S an intermediate for “Rifampicin” on treatment of Tuberculosis (TB)


2. Lovastatin



   Promoter holding 74.99% ( 48.50% Indian and  26.49% foreign  group), company posted 32cr top line and 4.5cr bottom line with 3.12EPS in fy 2014-15.



              ABOUT  FOREIGN PROMOTER GROUP :- YUHAN



After returning from the USA in 1925, Dr. Ilhan New witnessed the hardship in his country under Japanese imperialism. He founded the Yuhan corporation in 1926 with the belief that only healthy people could reclaim their sovereignty and he sought to solve widespread public health problems. Over 80 years, the founding creed to make the best medicines and contribute to public health has been succeeded by us through our intense research and development activities and successful collaboration with multinational pharmaceutical companies. As a result, Yuhan is one of the most respected companies in Korea for 20 consecutive years, according to the annual Korean Management Association Consulting (KMAC) survey. 



  Stock trading only in BSE @ 49 level, long term investor can buy @ current price and add more in correction (if any) this one stock can give huge profits in portfolio.




WEBSITE YUHAN HERE

WEBSITE GUJ THEMIS HERE

SHARE HOLDING PATTERN HERE


Before buying a stock take advice from certified person.

Disclosure :- I am holding this company shares.



               

9 comments:

  1. Thanks however the negative side of this stock is trading at 164.69 times its book value.

    ReplyDelete
  2. What are the growth prospects? Do you see any strong trigger in near future? BS is nothing good to like. Also, growth is not enticing. So, why one should invest here.

    I have Lincoln. If Themis has something special then I can move there.

    ReplyDelete
    Replies
    1. I am not force anyone to buy recommended stocks,i am looking this stock from different angles (promoters and group companies) if you not satisfied you have free to levees this counter.

      Delete
  3. Hi can u tell me if they are going to introduce any new products? Did u talk to the management? Any idea about wat kind of sales they will be looking to achieve for the full year? The company is certainly very promising

    ReplyDelete
  4. Hello sir, can you add a stocks track report or log report which shows all your recommended stocks till date and how they have performed over period of time?

    ReplyDelete
  5. Hi Sir,

    Can you please let me know your view on HMVL ?

    Thanks,
    Srinivas Attaluri

    ReplyDelete
  6. Nice stock. Quickly coming out of its bad days. Found this stock last year in october and promptly bought at 21. With a small equity base and good promoters I am sure it will give more capital appreciation to me.

    Thanks Sir, your research gives me more confidence to hold for next five years atleast.

    Request you to have a look at Patels Airtemp also and give your views.

    ReplyDelete